待处理
入排:排除
图源:待检查
Correction: Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial.
Bruno Dubois, Jesús López-Arrieta, Stanley Lipschitz, Triantafyllos Doskas, Luiza Spiru, Svitlana Moroz, Olena Venger, Patrick Vermersch, Alain Moussy, Colin D Mansfield, Olivier Hermine, Magda Tsolaki, AB09004 Study Group Investigators
Alzheimers Res Ther 15(1) 85
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板